RankAlpha logo
Back to Rankings

IMUX

ImmunicF
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Below peers
vs peer average
IMUX vs peer average
28/100
IMUX vs. peer average (F vs. D)
Grade spread
B 2 · C 3 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

MREO is the first available peer comparator.

Development-stage biotech where valuation is also driven by discrete clinical milestones; useful as a binary-event comp, though not a close operating peer in multiple sclerosis.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerMREOMereo BioPharma Group
IMUX
Immunic
MREO
Mereo BioPharma Group
Grade
F
C
Momentum
80
91
Value
41
41
Sentiment
0
29
Setup Bias
Net —
-
Market Cap
-
-
Posture
Defensive
Mixed
Open Side-by-Side ComparisonCompare all

Grade position vs MREO

IMUX / MREO
Grade Position
Below peers
IMUX vs. peer average (F vs. D)
28/100
Momentum
80
MREO
Value
41
IMUX
Sentiment
0
MREO

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs IMUX
1
MREO
MREO
C
60/100
-2
2
IFRX
IFRX
F
20/100
Even
3
KRRO
KRRO
C
60/100
-2
4
WHWK
Whitehawk Therapeutics Inc Common
F
20/100
Even
5
NERV
Minerva Neurosciences Inc Common
B
80/100
-3
MREO is the first peer returned for this comparison set.